Medicare Enrolled
Dr. Richard Gorman, MD
Medical Oncology · New Bern, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gorman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gorman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gorman
Dr. Richard Gorman is a medical oncology specialist in New Bern, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gorman performed 1,800 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gorman received a total of $8,284 from 69 pharmaceutical and/or device companies across 488 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gorman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in NC
$8,284 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,800
Medicare services
Top 12% in NC for medical oncology
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
798 | $70 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
461 | $44 | $157 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
196 | $61 | $176 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
190 | $107 | $328 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
80 | $135 | $467 |
| New patient office visit, complex (60-74 min) | 61 | $137 | $435 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $85 | $349 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,284
Total received (2018-2024)
Avg $1,183/year across 7 years
Top 34% in NC for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
488
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,165
2023
$420
2022
$570
2021
$447
2020
$288
2019
$2,811
2018
$2,582
Payments by company (2024)
Merck Sharp & Dohme LLC
$180
PFIZER INC.
$108
AstraZeneca Pharmaceuticals LP
$106
Incyte Corporation
$100
GENZYME CORPORATION
$64
Janssen Biotech, Inc.
$62
Regeneron Healthcare Solutions, Inc.
$46
Rigel Pharmaceuticals, Inc.
$39
Celgene Corporation
$35
Tempus AI, Inc
$33
Pharmacosmos Therapeutics Inc.
$32
PharmaEssentia USA Corporation
$31
Genentech USA, Inc.
$26
Dendreon Pharmaceuticals LLC
$25
Daiichi Sankyo Inc.
$25
Sirtex Medical Inc
$24
BioMarin Pharmaceutical Inc.
$22
BeiGene USA, Inc.
$20
Blue Earth Diagnostics Limited
$19
EMD Serono, Inc.
$19
Lilly USA, LLC
$19
ABBVIE INC.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Gilead Sciences, Inc.
$17
GlaxoSmithKline, LLC.
$16
Astellas Pharma US Inc
$15
JAZZ PHARMACEUTICALS INC.
$15
Adaptive Biotechnologies Corporation
$14
Eisai Inc.
$14
Top 3 companies account for 33.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$683
PFIZER INC.
$507
AstraZeneca Pharmaceuticals LP
$486
Genentech USA, Inc.
$467
Amgen Inc.
$409
E.R. Squibb & Sons, L.L.C.
$407
Incyte Corporation
$332
Celgene Corporation
$316
Novartis Pharmaceuticals Corporation
$299
Astellas Pharma US Inc
$276
Dendreon Pharmaceuticals LLC
$247
Merck Sharp & Dohme Corporation
$227
GENZYME CORPORATION
$220
Merck Sharp & Dohme LLC
$211
Bayer HealthCare Pharmaceuticals Inc.
$199
Seagen Inc.
$190
Seattle Genetics, Inc.
$175
Lilly USA, LLC
$158
Takeda Pharmaceuticals U.S.A., Inc.
$146
Gilead Sciences, Inc.
$137
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
EMD Serono, Inc.
$108
Exelixis Inc.
$103
Alexion Pharmaceuticals, Inc.
$96
SANOFI-AVENTIS U.S. LLC
$89
TESARO, Inc.
$89
Pharmacyclics LLC, An AbbVie Company
$85
Janssen Pharmaceuticals, Inc
$83
AbbVie, Inc.
$75
Daiichi Sankyo Inc.
$74
Ipsen Biopharmaceuticals, Inc
$68
Rigel Pharmaceuticals, Inc.
$65
AMAG Pharmaceuticals, Inc.
$61
Puma Biotechnology, Inc.
$61
Regeneron Healthcare Solutions, Inc.
$58
Kyowa Kirin, Inc.
$57
GlaxoSmithKline, LLC.
$51
MEDIVATION FIELD SOLUTIONS LLC
$49
Eisai Inc.
$49
Lexicon Pharmaceuticals, Inc.
$47
Verastem, Inc.
$45
Clovis Oncology, Inc.
$45
Sirtex Medical Inc
$43
Taiho Oncology, Inc.
$41
BeiGene USA, Inc.
$40
Agios Pharmaceuticals, Inc.
$35
Tempus AI, Inc
$33
Dova Pharmaceuticals
$32
INSYS Therapeutics Inc
$32
Pharmacosmos Therapeutics Inc.
$32
PharmaEssentia USA Corporation
$31
Myovant Sciences Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
BioMarin Pharmaceutical Inc.
$22
Sun Pharmaceutical Industries Inc.
$20
CTI BioPharma Corp.
$20
Blue Earth Diagnostics Limited
$19
ABBVIE INC.
$19
SERVIER PHARMACEUTICALS LLC
$17
Myriad Genetic Laboratories, Inc.
$17
ADC Therapeutics America, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Adaptive Biotechnologies Corporation
$14
Kite Pharma, Inc.
$14
Novocure Inc.
$14
Shire North American Group Inc
$14
Immunocore Limited
$13
CSL Behring
$12
G1 Therapeutics, Inc.
$11
Top 3 companies account for 20.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BESREMI · BOSULIF · BRACAnalysis CDx · BRUKINSA · Bavencio · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Erleada · FARESTON · FERAHEME · GAZYVA · GILOTRIF · Haegarda · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · Inrebic · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · PEMAZYRE · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Pomalyst · REBLOZYL · ROCTAVIAN · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TREANDA · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONVENDI · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XT CDX · XTANDI · Xermelo · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
2
County median income
$64,635
Nearest hospital to ZIP centroid (approximate)
CAROLINA EAST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gorman is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NC), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gorman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gorman performed 798 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gorman receive payments from pharmaceutical companies?
Yes. Dr. Gorman received a total of $8,284 from 69 companies across 488 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gorman's costs compare to other medical oncologists in New Bern?
Dr. Gorman's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gorman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in New Bern
Browse medical oncologists in New Bern ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NC
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NC
Which NC medical oncologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology